New Exec Director Roles...Selling Brillinta?!?

Anonymous

Guest
We have taken the incompetence to another level. We are actually paying director level salaries to help influence the hospital environment. Now we can have a broad range of salaries going into these accounts, telling them that we really don't have much to offer, and listening explain to us that this product will not be used in their institutions. Wow...this is really getting fun.
 

<



We have taken the incompetence to another level. We are actually paying director level salaries to help influence the hospital environment. Now we can have a broad range of salaries going into these accounts, telling them that we really don't have much to offer, and listening explain to us that this product will not be used in their institutions. Wow...this is really getting fun.

Whhaaaatttt??? AZ has taken another desperate turn in trying to make this dead product something it will never be. Brilinta will go down as the WORST launch of a product, well, since Vimovo!! HA! HA! HA! HA!
 








Whhaaaatttt??? AZ has taken another desperate turn in trying to make this dead product something it will never be. Brilinta will go down as the WORST launch of a product, well, since Vimovo!! HA! HA! HA! HA!


Everyone needs to be positive here!!
We can work to make this succcessful with
the right winning attitude it can propel you to
new heights!!

Hey this is a great opportunity!!

Mentally focus on the opportunity!!
 








i think that Pascal should go through product training, then spend 3 months doing exactly what his own reps have to do each day. THEN, and only then, will he have an understanding of the real challenges of doing this job in the field, and how utterly senseless all the consultants are.
 




We have taken the incompetence to another level. We are actually paying director level salaries to help influence the hospital environment. Now we can have a broad range of salaries going into these accounts, telling them that we really don't have much to offer, and listening explain to us that this product will not be used in their institutions. Wow...this is really getting fun.

HAHAHAHA
AZ will never get a product launch right!!!
 




What cracks me up is that any fresh out of college marketing analyst knows that trying to launch a premium-priced brand against a market leader gone generic is a complete loser proposition. This should have been called years ago and the R&D go/no go decision should have been no!
 




What cracks me up is that any fresh out of college marketing analyst knows that trying to launch a premium-priced brand against a market leader gone generic is a complete loser proposition. This should have been called years ago and the R&D go/no go decision should have been no!

It seems obvious to even the untrained eye.
 




What cracks me up is that any fresh out of college marketing analyst knows that trying to launch a premium-priced brand against a market leader gone generic is a complete loser proposition. This should have been called years ago and the R&D go/no go decision should have been no!

They are all naive and ignorant to the real market forces. They honestly believe thy are competing against brands, rather than against compounds, or therapy regimens. They also believe that the customer is a Dr, rather than the payer. They'd be better off to focus marketing to thepayers first, to save the payers $ with a true value-add prop. Nope. Instead, they consider prescribers to be malleable patsies for the canned marketing messages. Sad but true. Most marketing folks in pharma just don't know what they don't know, that the third party payer is the real customer, and the prescriber office is only a distribution channel.
 




They are all naive and ignorant to the real market forces. They honestly believe thy are competing against brands, rather than against compounds, or therapy regimens. They also believe that the customer is a Dr, rather than the payer. They'd be better off to focus marketing to thepayers first, to save the payers $ with a true value-add prop. Nope. Instead, they consider prescribers to be malleable patsies for the canned marketing messages. Sad but true. Most marketing folks in pharma just don't know what they don't know, that the third party payer is the real customer, and the prescriber office is only a distribution channel.

Brilliant and so true.